You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

AUVI-Q Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Auvi-q patents expire, and when can generic versions of Auvi-q launch?

Auvi-q is a drug marketed by Kaleo Inc and is included in one NDA. There are twenty patents protecting this drug.

This drug has one hundred and twelve patent family members in fourteen countries.

The generic ingredient in AUVI-Q is epinephrine. There are twenty-one drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the epinephrine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Auvi-q

A generic version of AUVI-Q was approved as epinephrine by BPI LABS on July 29th, 2014.

  Try a Trial

US Patents and Regulatory Information for AUVI-Q

AUVI-Q is protected by twenty US patents.

Patents protecting AUVI-Q

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Medicament delivery device and methods for delivering drugs to infants and children
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: METHOD OF TREATING AN ALLERGIC REACTION USING AN AUTO-INJECTOR

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Medicament delivery device and methods for delivering drugs to infants and children
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: METHOD OF TREATING AN ALLERGIC REACTION USING AN AUTO-INJECTOR


Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial


Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: METHOD OF TREATING AN ALLERGIC REACTION USING AN AUTO-INJECTOR

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Medicament delivery device configured to produce an audible output
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Medical injector with compliance tracking and monitoring
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Medicament delivery device having an electronic circuit system
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Devices, systems, and methods for medicament delivery
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: METHOD OF TREATING ALLERGIC REACTION VIA INJECTION

Devices, systems, and methods for medicament delivery
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: METHOD FOR CONFIRMING DOSE DELIVERY

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Devices, systems and methods for medicament delivery
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: METHOD TO TREAT SEVERE ALLERGIC EMERGENCIES IN PATIENTS WEIGHING 7.5 TO 15 KG (16.5 TO 33 LBS)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kaleo Inc AUVI-Q epinephrine SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 201739-001 Aug 10, 2012 BX RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Kaleo Inc AUVI-Q epinephrine SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 201739-002 Aug 10, 2012 BX RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Kaleo Inc AUVI-Q epinephrine SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 201739-001 Aug 10, 2012 BX RX Yes No ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for AUVI-Q

See the table below for patents covering AUVI-Q around the world.

Country Patent Number Title Estimated Expiration
United Kingdom 2449027 Devices, systems and methods for medicament delivery ⤷  Try a Trial
Canada 2791286 DISPOSITIFS, SYSTEMES ET PROCEDES D'ADMINISTRATION DE MEDICAMENTS (DEVICES, SYSTEMS, AND METHODS FOR MEDICAMENT DELIVERY) ⤷  Try a Trial
United Kingdom 0822532 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.